Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 2020.00 | 1732.50 | 1.1659 | 1.2428 |
| BT-20 | Lapatinib | 1 | uM | 9 | 1250.00 | 684.27 | 1909.00 | 1732.50 | 1.1019 | 1.1501 |
| BT-20 | Linsitinib | 10 | uM | 9 | 1250.00 | 684.27 | 1531.00 | 1732.50 | 0.8837 | 0.8237 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1598.00 | 1732.50 | 0.9224 | 0.8830 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1158.00 | 1732.50 | 0.6684 | 0.4807 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1943.00 | 1732.50 | 1.1215 | 1.1787 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1899.00 | 1732.50 | 1.0961 | 1.1417 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 684.27 | 1143.00 | 1732.50 | 0.6597 | 0.4664 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1424.00 | 1732.50 | 0.8219 | 0.7278 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 684.27 | 1828.00 | 1732.50 | 1.0551 | 1.0817 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1743.00 | 1732.50 | 1.0061 | 1.0090 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 684.27 | 1491.00 | 1732.50 | 0.8606 | 0.7881 |
| BT-20 | Linsitinib | 1 | uM | 9 | 1250.00 | 684.27 | 1607.00 | 1732.50 | 0.9276 | 0.8909 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1422.00 | 1732.50 | 0.8208 | 0.7260 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1589.00 | 1732.50 | 0.9172 | 0.8751 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 805.00 | 1732.50 | 0.4647 | 0.1289 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1421.00 | 1732.50 | 0.8202 | 0.7251 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1906.00 | 1732.50 | 1.1001 | 1.1476 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1909.00 | 1732.50 | 1.1019 | 1.1501 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 2119.00 | 1732.50 | 1.2231 | 1.3243 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 1250.00 | 684.27 | 1989.00 | 1732.50 | 1.1481 | 1.2170 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2056.00 | 1732.50 | 1.1867 | 1.2725 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 684.27 | 1935.00 | 1732.50 | 1.1169 | 1.1720 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 2129.00 | 1732.50 | 1.2289 | 1.3324 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1963.00 | 1732.50 | 1.1330 | 1.1954 |